Cargando…

Simvastatin induced ferroptosis for triple-negative breast cancer therapy

Triple-negative breast cancer (TNBC), a management of aggressive breast cancer, remains an unmet medical challenge. Although a wave of efforts had spurred to design novel therapeutic method of TNBC, unpredictable prognosis with lacking effective therapeutic targets along with the resistance to apopt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Xianxian, Xie, Ruihong, Cao, Yongbin, Tang, Jing, Men, Yongzhi, Peng, Haibao, Yang, Wuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502296/ https://www.ncbi.nlm.nih.gov/pubmed/34627266 http://dx.doi.org/10.1186/s12951-021-01058-1

Ejemplares similares

Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy
por: Guo, Shengdi, et al.
Publicado: (2020)

Defect self-assembly of metal-organic framework triggers ferroptosis to overcome resistance
por: Peng, Haibao, et al.
Publicado: (2021)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis
por: Chen, Hsin-Chih, et al.
Publicado: (2022)

Simvastatin functions as a heat shock protein 90 inhibitor against triple‐negative breast cancer
por: Kou, Xinhui, et al.
Publicado: (2018)

Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

Integrated profiling uncovers prognostic, immunological, and pharmacogenomic features of ferroptosis in triple-negative breast cancer
por: Fang, Kun, et al.
Publicado: (2022)

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
por: Zhao, Hongting, et al.
Publicado: (2023)

New Application of Old Material: Chinese Traditional Ink for Photothermal Therapy of Metastatic Lymph Nodes
por: Wang, Sheng, et al.
Publicado: (2017)

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
por: Yu, Mengyu, et al.
Publicado: (2019)

Curcumin suppresses tumorigenesis by ferroptosis in breast cancer
por: Cao, Xuelei, et al.
Publicado: (2022)

PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis
por: Wang, Zhe, et al.
Publicado: (2023)

Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy
por: Zhang, Liren, et al.
Publicado: (2019)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
por: Song, Xiang, et al.
Publicado: (2020)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells
por: Duan, Xianxian, et al.
Publicado: (2022)

HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk
por: Li, Hengyu, et al.
Publicado: (2022)

LncRNA HCP5-Encoded Protein Regulates Ferroptosis to Promote the Progression of Triple-Negative Breast Cancer
por: Tong, Xiao, et al.
Publicado: (2023)

Triple-negative breast cancer and the potential for targeted therapy
por: Jhan, Jing-Ru, et al.
Publicado: (2017)

Identification of FOXM1 as a specific marker for triple-negative breast cancer
por: Tan, Yanli, et al.
Publicado: (2018)

Triple-negative breast cancer and radiation therapy
por: de Faria Bessa, Jordana, et al.
Publicado: (2022)

Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
por: Xu, Shuo, et al.
Publicado: (2023)

Application of Novel Transcription Factor Machine Learning Model and Targeted Drug Combination Therapy Strategy in Triple Negative Breast Cancer
por: Pang, Jianyu, et al.
Publicado: (2023)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer
por: Luo, Zimiao, et al.
Publicado: (2023)

Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer
por: Tang, Yuxia, et al.
Publicado: (2022)

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism
por: Li, Pengyun, et al.
Publicado: (2022)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
por: Maccallini, Cristina, et al.
Publicado: (2022)

Ultrasound-Targeted Microbubble Disruption with Key Nanodroplets for Effective Ferroptosis in Triple-Negative Breast Cancer Using Animal Model
por: Liu, Rui, et al.
Publicado: (2023)

A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis
por: Zhao, Peng, et al.
Publicado: (2023)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells
por: Ding, Yahui, et al.
Publicado: (2021)

Upregulation of the ferroptosis-related STEAP3 gene is a specific predictor of poor triple-negative breast cancer patient outcomes
por: Yuan, Lifang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_863rukdisq2v9n24n2o193u6nq